17 studies found for:    "West nile virus"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed West Nile Virus Natural History
Condition: West Nile Virus
Intervention:
2 Completed Natural History of West Nile Virus Infection
Conditions: West Nile Virus;   Encephalitis;   Myelitis
Intervention:
3 Terminated
Has Results
Treatment of West Nile Virus With MGAWN1
Conditions: West Nile Neuroinvasive Disease;   West Nile Virus Infection;   Encephalitis;   Meningitis;   Acute Flaccid Paralysis;   West Nile Fever
Interventions: Biological: MGAWN1;   Biological: Placebo - normal saline
4 No longer available Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure
Condition: West Nile Virus Infection
Intervention: Biological: MGAWN1
5 Completed Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease
Condition: West Nile Virus
Intervention: Drug: Omr-IgG-am
6 Recruiting Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age
Condition: West Nile Virus
Interventions: Biological: WN/DEN4Δ30 Vaccine;   Biological: Placebo
7 Completed IVIG - West Nile Encephalitis: Safety and Efficacy
Condition: West Nile Virus
Interventions: Drug: Omr-lgG-am;   Drug: Polygam® S/D;   Drug: Placebo
8 Completed A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy Adults
Condition: West Nile Virus
Interventions: Drug: MGAWN1;   Other: Placebo
9 Completed Safety Study of HBV-002 West Nile Vaccine in Healthy Adults
Condition: West Nile Virus Disease
Intervention: Biological: WN-80E
10 Completed Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020
Condition: West Nile Virus
Intervention: Drug: AVI-4020 Injection
11 Completed Phase I Study of West Nile Virus Vaccine
Condition: West Nile Fever
Intervention: Drug: VRC-WNVDNA020-00-VP
12 Completed Retrovirus Epidemiology Donor Study-II (REDS-II)
Conditions: Acquired Immunodeficiency Syndrome;   Blood Donors;   Blood Transfusion;   HIV Infections;   HIV-1;   HIV-2;   HTLV-I;   HTLV-II;   Retroviridae Infections;   Hepatitis, Viral, Human;   Hepatitis B;   Hepacivirus;   West Nile Virus
Intervention:
13 Completed Vaccine to Prevent West Nile Virus Disease
Conditions: Healthy;   West Nile Fever;   Healthy Volunteer;   HV
Intervention: Drug: VRC-WNVDNA017-00-VP
14 Terminated An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease
Condition: West Nile Fever
Intervention: Drug: AVI-4020 Injection
15 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: WN/DEN4delta30 vaccine;   Biological: Placebo
16 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults
Condition: West Nile Fever Encephalitis
Interventions: Biological: WN/DEN4-3'delta30;   Biological: Placebo
17 Completed
Has Results
Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: ChimeriVax-WN02 vaccine;   Biological: Placebo

Indicates status has not been verified in more than two years